Previous reports also demonstrated that genetic variations of RARβ affect prostate cancer susceptibility[39].To further confirm RARβ2 promoter methylation status in prostate cancer patient' s diagnosis, we carried out a meta-analysis of 12 studies involving 777 cases and 404 controls to derive a more precise estimation of the association. The gene discussed is RARB; the disease is prostate carcinoma.